| 20.10.2009 | Influence of CYP11A1 (TTTTA)n polymorphism on disease progression, serum androgens, prognosis and risk in men with prostate cancer | Jóhann Gunnar Jónsson 1982- |
| 20.10.2009 | Effects of polymorphic NAT2 on thalidomide treatment in prostate cancer | Silja Þórðardóttir 1982- |
| 3.5.2010 | Þróun á HPLC-MS/MS aðferð til magngreiningar á sterum með hönnun tilrauna | Finnur Freyr Eiríksson 1982- |
| 4.5.2010 | Þróun á sýnameðhöndlun til magngreiningar á amínósýrum með LC-MS/MS mæliaðferð | Helga Hrund Guðmundsdóttir 1984- |
| 10.5.2010 | Þróun aðferðar til mælinga á umbrotsefni heróíns, 6-mónóasetýlmorfíns (6-MAM) í lífsýnum | Íris Rún Þórðardóttir 1984- |
| 2.5.2011 | Targeted Lipid Analysis in Cultured Cancer Cells: Effects of Protolichesterinic Acid on Lipid Composition | Kári Skúlason 1986- |
| 3.5.2011 | Development of a LC-MS/MS Method for the Quantification of Cortisol and Cortisone | Arndís Sue Ching Löve 1985- |
| 5.5.2011 | Þróun á LC-MS/MS aðferð fyrir magngreiningu á 25-hýdroxý-D-vítamíni - með hönnun tilrauna | Hannes Þórður Þorvaldsson 1983- |
| 30.4.2012 | Quantification of the Lipids 5-HETE, 12-HETE and LTB4 in Cultured Cancer Cells after Treatment with Protolichesterinic Acid | Sigríður Þóra Kristinsdóttir 1986- |
| 30.4.2013 | Þróun á HPLC-MS/MS aðferð til magngreiningar á fólinsýru og hómósysteini | Dyla, Saranda, 1984- |
| 2.5.2013 | Effects of Protolichesterinic Acid on Lipid Composition in Cultured Cancer Cells | Signý Jóhannesdóttir 1987- |
| 17.5.2013 | Development of a sample preparation method for the detection and identification of cholesterol in a Parkinson’s disease model utilizing MALDI-MSI | Ingólfur Birgisson 1988- |
| 30.4.2014 | Evaluation of Lipid Composition in Several Cancer Cell Lines by Mass Spectrometry | Andri Hallgrímsson 1986- |
| 8.1.2016 | Simultaneous imaging and relative quantitation of multiple neurotransmitters in a progressive Parkinson's disease model by MALDI-MSI | Elva Friðjónsdóttir 1990- |
| 28.4.2016 | Pre-validation of UPLC-QqQ-MS/MS Procedure for Quantification of 2,8-Dihydroxyadenine in Human Urine | Guðrún Linda Sveinsdóttir 1991- |
| 28.4.2016 | Optimization of Quantitative Clinical UPLC-MSMS Method for 2,8-Dihydroxyadenine and Oxypurinol with Design of Experiement | Ómar Rafn Stefánsson 1985- |
| 28.4.2017 | Development of highly sensitive LC-ESI MS/MS method for neurotransmitters and MALDI imaging analysis on β-N-methylamino-L-alanine (BMAA) neurotoxin | Ásdís Alexandra Lee 1992- |
| 2.5.2017 | Sample Preparation Strategies for Breast Cancer Studies: Focus on Alpha-1-Acid Glycoprotein by means of MALDI-TOF mass spectrometry | Auðunn Rúnar Gissurarson 1991- |
| 25.4.2018 | Development of UPLC-MS/MS method for therapeutic drug monitoring for patients with APRT deficiency | Þorsteinn Hjörtur Bjarnason 1990- |
| 25.4.2018 | Lipidomic profiling of cancer cell lines using multivariate data analysis | Rebekka Rós Baldvinsdóttir 1990- |
| 25.4.2018 | A MALDI-MSI method to detect neuropeptides in the basal ganglia of the brain | Halla Gunnarsdóttir 1991- |
| 31.1.2019 | Athugun á þéttni/styrk beta-laktam lyfja sem gefin eru með langtíma innrennsli hjá sjúklingum sem fá meðferð utan sjúkrahúss | Andri Örn Erlingsson 1984- |
| 29.4.2019 | Development of UPLC-MS/MS method for quantification of cefazolin and flucloxacillin for quality analysis of OPAT elastomeric pumps | Snæfríður Dröfn Pétursdóttir 1992- |
| 29.4.2019 | Metabolic profiling of cyanobacterial extracts using multivariate data analysis for their anti-obesity properties | Baldvin Gestsson 1992- |
| 29.4.2019 | Labeling of human cells using 13C labeled nutrients and metabolite tracking in co-culture | Gunnar Jökull Johns 1994- |
Íslenska
